JPMorgan raised the firm’s price target on Veeva (VEEV) to $290 from $274 and keeps a Neutral rating on the shares. The company’s billings showed “lumpiness” in fiscal Q2 but management sees better visibility going forward, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
